| Pharmaceutical active ingredients: |
| ChlorquinaldolDiflucortolone Valerate |
| Available forms, composition and doses of Bi-Nerisona: |
| Cream; Topical; Chlorquinaldol 1%; Diflucortolone Valerate 0.1% |
| Bi-Nerisona medical category: |
| Human:Topical anti-infectives with corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07BC04 - Diflucortolone and antisepticsG01AC03 - Chlorquinaldol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Quinortar | Chlorquinaldol; Coal Tar; Titanium Dioxide | Faes Farma |
| Sirinal | Chlorquinaldol; Dequalinium Chloride | Woelm Pharma |
| Tyrosirinal | Chlorquinaldol; Dequalinium Chloride; Tyrothricin | Woelm Pharma |
| Proctospre | Chlorquinaldol; Dibucaine; Diphenylpyraline | Sanofi-Aventis; Hennig Arzneimittel; Medimport, Czech Republic |
| Binerisona | Chlorquinaldol; Diflucortolone Valerate | Bayer Schering Pharma |
| Claral Plus | Chlorquinaldol; Diflucortolone Valerate | Bayer Schering Pharma |
| Impetex | Chlorquinaldol; Diflucortolone Valerate | Roche |
| Multiderm | Chlorquinaldol; Diflucortolone Valerate | Perrigo |
| Neriquinol | Chlorquinaldol; Diflucortolone Valerate | Bayer Schering Pharma |
| Nerisona C | Chlorquinaldol; Diflucortolone Valerate | Bayer Schering Pharma; Chiesi; Intendis |